Active Care Model Predicts Disease Course for Prostate Cancers

Active Care Model Predicts Disease Course for Prostate Cancers

For many men, prostate cancers are extremely slow-growing — patients often can be monitored periodically through blood tests, biopsies and MRI without necessarily needing treatment. Johns Hopkins experts have a precision medicine tool — called Active Care — that employs sophisticated statistical modeling and all of the patient’s prostate-specific antigen (PSA) protein level tests, biopsy results and other clinical information to estimate the chance that the cancer is slow-growing or more aggressive.

 READ HERE
SEE ALL NEWS
Recent Posts
5 Healthy Habits That Help During Cancer Treatment Understanding Mammogram Results A 19-Year Fight Against Prostate Cancer Brings Man to Johns Hopkins Medicine Scientists Advance Efforts to Create ‘Virtual Cell Lab’ As Testing Ground for Future Research with Live Cells Ultra-Processed Foods: Q&A with 2 Dietitians Radiation Therapy Overcomes Immunotherapy Resistance in Some Cancers ‘Power Surges’ on Cancer Cell Membranes May Fuel Progression of Disease New Cancer Target Discovered How surgeons build a new bladder for cancer patients like Deion Sanders